https://finance.yahoo.com/news/coherus-biosciences-acquires-small-immuno-140011214.html
Coherus BioSciences Inc (NASDAQ: CHRS) has agreed to acquire Surface Oncology Inc (NASDAQ: SURF), a clinical-stage immuno-oncology (I-O) company developing...
Create an account or login to join the discussion